Tenn. Comp. R. & Regs. 0940-05-42-.12 - SPECIAL POPULATIONS
(1) The OTP shall
ensure that physicians are knowledgeable in the management of opioid dependence
in a context of chronic pain and pain management. The OTP may not prohibit a
service recipient diagnosed with chronic pain from receiving
medication-assisted therapy for either maintenance or withdrawal in a program
setting.
(a) The OTP shall ensure continuity
of care and communication between programs or physicians regarding service
recipients receiving treatment in both an opioid treatment program and a
facility or physician's office for purposes of pain management, with service
recipient consent.
(b) If the
service recipient refuses consent for the two entities to communicate and
coordinate care, the OTP shall document refusal and may make clinically
appropriate decisions regarding take-home medication privileges, an increase in
counseling, and continuation in treatment.
(2) The OTP shall ensure that service
recipients with mental health needs are identified through the evaluation
process and referred to appropriate treatment.
(a) The OTP shall monitor service recipients
during withdrawal to identify the emergence of symptoms of mental
illness.
(b) The OTP shall
establish linkages with mental health providers in the community.
(3) The Facility shall have a
policy regarding treatment of co-morbid disorders such as psychiatric and
medical disorders. The goal of the treatment shall be to provide treatment for
these disorders in as seamless a fashion as possible, maximizing service
recipient convenience and compliance with appointments and recommendations. The
Facility shall ensure a smooth referral process and interchange of
information.
(4) The OTP shall
address abuse of alcohol and other non-opioid substances within the context of
the medication-assisted therapy effort.
(a)
The Facility shall ensure that staff is trained and knowledgeable regarding
current effective strategies for treating abuse of alcohol, opioids, methadone,
amphetamines, cocaine, barbiturates, benzodiazepines and other drugs.
(b) Ongoing multi-drug use is not necessarily
a reason for discharge unless the service recipient refuses recommended, more
intensive levels of care, to include but not be limited to intensive outpatient
and residential clinical treatment. The treatment team shall consider the
service recipient's condition and address the situation from an individualized
clinical perspective.
Notes
Authority: T.C.A. ยงยง 4-3-1601, 4-4-103, 33-1-302, 33-1-305, 33-1-309, 33-2-301, 33-2-302, and 33-2-404.
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.